FINWIRES · TerminalLIVE
FINWIRES

Wayfair Adjusted Earnings Miss Views Amid 'Choppy' Start to 2026 for Home Furnishings

作者

-- Wayfair (W) shares tumbled Thursday after the company's first-quarter adjusted earnings fell short of Wall Street's estimates as it navigates a tough macro backdrop amid a "choppy" start to 2026 for the home furnishings category.

The online furniture and home goods retailer's adjusted earnings rose to $0.26 a share for the March quarter from $0.10 a year earlier. Those results missed the Street's views for $0.28. Revenue increased 7.4% to $2.93 billion, exceeding the Street's projections for $2.89 billion.

The home furnishings category saw a "choppy" start to the year amid weather disruptions and higher fuel prices that slowed down consumer spending, Chief Executive Niraj Shah said on an earnings conference call, according to a FactSet transcript.

Wayfair expects the category to have been down in the low-single-digit range for the first quarter. This suggests the company outperformed the market by "a high-single-digit spread," according to Shah.

"This is a cyclical category, which is clearly in a down cycle," Shah told analysts. "While we believe we're due for a mean reversion, the timing remains hard to predict."

Wayfair shares were down nearly 12% in Thursday afternoon trade. The stock has slumped 35% so far this year.

The company saw first-quarter order growth of 3%, compared with a year earlier, Chief Financial Officer Kate Gulliver said on the call. "Within that, we saw a new order of growth of nearly 7% in the quarter, our best result since 2021, and saw our active customer growth finally flip to positive year-over-year after multiple quarters of positive sequential growth."

For the ongoing quarter, Wayfair expects top-line to grow by mid-single digits year over year, Gulliver told analysts.

"We're looking at a category that has been volatile in April so far, trending down in the mid-single-digit range," Gulliver said. "Our share spread has been holding nicely in the high-single-digit range."

Energy prices have surged following the US-Israel war with Iran that has left the crucial Strait of Hormuz effectively closed. The conflict paused following a recent ceasefire between Washington and Tehran, but a framework for a permanent truce is yet to be reached.

"We're continuing to closely watch the broader economic implications and how consumers are managing their wallets as they face higher prices at the gas pump," Shah said on the call.

Price: $66.24, Change: $-7.03, Percent Change: -9.59%

相关文章

Sectors

行业动态:金融

周四下午晚些时候,金融股走高,纽约证券交易所金融指数上涨1.3%,道富金融精选行业SPDR ETF(XLF)上涨0.5%。 费城住房指数上涨1.6%,道富房地产精选行业SPDR ETF(XLRE)上涨1.5%。 比特币(BTC-USD)上涨0.9%至76,409美元,10年期美国国债收益率下降2.8个基点至4.39%。 企业新闻方面,据彭博社报道,AvalonBay Communities(AVB)和Equity Residential(EQR)已就潜在的合并事宜展开磋商,这将是有史以来规模最大的房地产交易之一。AvalonBay股价下跌1.1%,Equity Residential股价小幅下跌。

$AVB$EQR
Australia

市场传闻:扎克伯格和库克并未考虑竞购西雅图海鹰队

据彭博社周四援引公司和业内消息人士报道,Meta Platforms (META) 首席执行官马克·扎克伯格和苹果公司 (AAPL) 首席执行官蒂姆·库克并未计划竞购美国国家橄榄球联盟 (NFL) 的西雅图海鹰队。 报道称,Meta 的一位发言人表示,扎克伯格没有对该球队进行任何投资或竞购,而一位熟悉库克计划的人士则否认了他参与此事。 Meta 和苹果公司均未立即回复的置评请求。 (市场闲谈新闻来源于与全球市场专业人士的对话。这些信息据信来自可靠来源,但可能包含传闻和猜测。准确性无法保证。)Price: $616.43, Change: $-52.69, Percent Change: -7.87%

$AAPL$META
Australia

Axsome Therapeutics公司称,FDA已批准Auvality用于治疗阿尔茨海默病躁动症。

Axsome Therapeutics (AXSM) 周四宣布,美国食品药品监督管理局 (FDA) 已批准其药物 Auveality 用于治疗阿尔茨海默病痴呆症相关的躁动症状。 该批准基于两项 3 期临床试验,结果显示,与安慰剂相比,Auveality 能显著改善躁动症状,并延长复发时间。 该公司补充说,该药物作用于大脑中的 N-甲基-D-天冬氨酸 (NMDA) 受体和 σ-1 受体,并且也获准用于治疗成人重度抑郁症。 Axsome 的股价在周四的交易中上涨超过 12%。Price: $206.45, Change: $+22.50, Percent Change: +12.23%

$AXSM